What You Should Know:
– The Digital Medicine Society (DiMe) and Elevance Health today announced a significant collaboration aimed at simplifying the identification of trustworthy digital health products.
– Elevance Health will provide a crucial clinical evidence assessment component to DiMe’s “DiMe Seal” program, further strengthening its evaluation of digital health software products (DHSPs).
DiMe Seal
The DiMe Seal, launched in 2024, is awarded to digital health solutions that meet high standards in usability, privacy, security, and evidence. This new partnership will integrate Elevance Health’s clinical evidence assessment, allowing DiMe to award its distinguished seal to DHSPs that satisfy all evaluation requirements, including robust clinical validation.
Navigating the Crowded Digital Health Landscape
With an overwhelming number of over 350,000 health apps currently available—including more than 30,000 specifically for clinicians and healthcare administrators—it has become increasingly challenging for users, providers, and payers to identify high-quality, trustworthy options. The DiMe Seal program was established to address this challenge by recognizing DHSPs that adhere to rigorous standards and are most likely to improve health outcomes. Each benchmark within the Seal’s criteria reflects a core value expected from a trusted product, and annual reviews will ensure ongoing compliance with the latest industry standards and guidelines.
Elevance Health to Provide Rigorous Clinical Evidence Assessment
A key enhancement to the DiMe Seal program will be the clinical evidence assessment provided by Elevance Health. This assessment is anchored in the Evidence DEFINED framework, a robust methodology created through a DiMe-led collaboration in 2023. This framework is designed to help payers and other organizations efficiently determine the clinical value of digital health products.
“To improve health outcomes at scale, it is critical for the digital health industry to move in an evidence-based direction. Elevance Health is proud to lead in the clinical evaluation of digital health software products,” said Jordan Silberman, MD, PhD, Director of Clinical Analytics & Research at Elevance Health. “Strategic partnerships and responsible innovation are essential for fostering trust in these products among individuals and their care teams.”
To start the process to obtain a DiMe Seal, or to learn more, click here.
